logo

For the Inventor, By the Inventor

Brisbane, CA, United States of America

Stéphane De Lombaert

This inventor holds 13 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Roivant Sciences Gmbh, Karos Pharmaceuticals, Inc., Altavant Sciences Gmbh. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stéphane De Lombaert. Retrieved from https://idiyas.com/inventor/stéphane-de-lombaert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 69.2

 

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 62(Granted Patents)


Location History:

  • Branford, CT (US) (2015 - 2016)
  • Brisbane, CA (US) (2017 - 2023)

Company Filing History:

goldMedal5 out of 5 
 
Roivant Sciences Gmbh
 patents
silverMedal3 out of 3 
 
Karos Pharmaceuticals, Inc.
 patents
bronzeMedal2 out of 8 
 
Altavant Sciences Gmbh
 patents
4. 2 out of 2 
 
Escape Bio, Inc.
 patents
5. 1 out of 1 
 
Kanos Pharmaceuticals, Inc.
 patent

Years Active: 2015-2023

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 11759462 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2023-09-19),
2. 11708365 - Processes for preparing TPH1 inhibitors (2023-07-25),
3. 11535632 - Solid forms of an S1P-receptor modulator (2022-12-27),
4. 11427558 - Indazoles and azaindazoles as LRRK2 inhibitors (2022-08-30),
5. 10946018 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2021-03-16),
6. 10710948 - Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1″-biphenyl]-2-yl)-2,2,2-trifluoroethanone (2020-07-14),
7. 10660893 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2020-05-26),
8. 10350208 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2019-07-16),
9. 10045988 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2018-08-14),
10. 9750740 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2017-09-05),
11. 9611201 - Processes for preparing (R)-1-(5-chloro-[1,1'-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone (2017-04-04),
12. 9512122 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2016-12-06),
13. 9199994 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2015-12-01),

Title: Stéphane De Lombaert - Inventor Extraordinaire

Introduction: Stéphane De Lombaert is a visionary inventor based in Brisbane, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Stéphane De Lombaert holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Stéphane De Lombaert has worked with leading tech companies, research institutions, and universities to bring his innovative ideas to life. His passion for creating solutions to complex problems has earned him recognition in the industry.

Collaborations: Stéphane De Lombaert has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of creativity and excellence in his projects. His ability to work across disciplines has led to the development of cutting-edge technologies.

Conclusion: Stéphane De Lombaert's dedication to innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs. His impact on the world of technology is truly remarkable.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…